The Food and Drug Administration on Friday ordered 19 active ingredients out of over-the-counter antibacterial hand and body washes after manufacturers failed to prove that the chemicals are safe for long-term daily use or more effective than ordinary soap and water.

The final rule covers liquid, foam, gel and bar products intended to be used with water and rinsed off. It includes triclosan and triclocarban, the two most prominent ingredients in consumer antibacterial soaps. Companies will have one year to reformulate affected products or remove them from the market, according to the agency’s September 2 announcement.

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said consumers may assume antibacterial washes prevent germs more effectively than plain soap. “In fact,” she said, “we do not have scientific evidence that they are any better.” The decision shifts the burden from habit and marketing to demonstrated safety and clinical benefit.

A three-year demand for evidence reaches a verdict

The agency proposed tighter requirements in 2013, asking manufacturers to supply modern data on long-term exposure and on whether their products actually prevent illness and infection better than plain soap. A contemporaneous account of that proposal described FDA concerns that widespread daily use had outpaced the evidence supporting the products.

Manufacturers did not provide sufficient information for 19 ingredients. The final rule therefore finds that those chemicals are not generally recognized as safe and effective for consumer antiseptic washes marketed without an approved drug application. Infection Control Today’s report on the decision detailed the agency’s conclusion that the missing proof applied to both long-term safety and superiority over ordinary washing.

The rule does not declare that every exposure causes harm. It says the public record does not meet the evidentiary standard required for products used repeatedly by millions of people. That distinction is central: a consumer drug ingredient must earn its place through adequate data, not merely remain on shelves because it has been sold for years.

Triclosan becomes the symbol of a broader review

Triclosan has been used in liquid soaps and many other consumer products, while triclocarban has been common in bar soaps. Laboratory and animal research has raised questions about hormonal effects, and public-health researchers have examined whether widespread antimicrobial use can contribute to resistance. Those signals do not all translate directly into proven human harm, but they strengthened the FDA’s demand for exposure and effectiveness studies.

An earlier review in the Centers for Disease Control and Prevention’s journal found that antibacterial household products had not demonstrated a clear health advantage for consumers and warned that indiscriminate use could create selective pressure favoring resistant organisms. The final rule brings that long-running scientific debate into consumer-drug regulation.

Rolf Halden, an environmental-health scientist at Arizona State University, called the action a public-health and environmental victory. Arizona State’s September 2 account described research tracing antimicrobial chemicals through wastewater and into the environment, where continued exposure extends beyond the bathroom sink.

Plain soap remains the standard for homes

The FDA’s message to consumers is direct: wash with plain soap and water. The mechanical action of washing loosens dirt and microbes, and rinsing carries them away. Where soap and water are unavailable, the agency recommends an alcohol-based hand sanitizer containing at least 60 percent alcohol.

The new rule does not cover alcohol-based hand sanitizers, antiseptic wipes or antibacterial products used in hospitals and other health-care settings. Those uses involve different formulations, risks and clinical circumstances and are being considered separately. Time’s report on Friday’s action emphasized that the order applies to wash-off consumer products rather than every product carrying an antimicrobial claim.

That scope also explains why antibacterial soaps can disappear from household aisles without affecting surgeons’ scrubs or hospital infection-control protocols. The decisive question is not whether antimicrobial chemistry has value anywhere, but whether a specific ingredient in a specific everyday product has been shown safe and beneficial under its conditions of use.

Industry reformulation is already underway

Many manufacturers have begun removing triclosan and triclocarban in anticipation of the rule. The FDA deferred decisions on three other ingredients—benzalkonium chloride, benzethonium chloride and chloroxylenol—to allow additional data collection. Products using those chemicals may remain on the market while the agency reviews the evidence.

GOJO Industries, maker of Purell products, said its consumer hand soaps do not contain the 19 ingredients covered by the rule. The company’s September 2 corporate statement also stressed that hand sanitizers fall outside the action. Such responses show how manufacturers are distinguishing among ordinary soaps, antiseptic washes and leave-on rubs.

Public-health specialists generally welcomed the FDA’s insistence on proof. STAT’s coverage of the rule described researchers’ concern that consumers had been encouraged to purchase “antibacterial” protection without evidence of fewer infections in routine household use.

A regulatory lesson reaches beyond the soap aisle

The decision is consequential because antibacterial labeling has often operated as a shorthand for superior hygiene. The FDA is now separating that marketing proposition from the evidence: killing bacteria in a laboratory test is not the same as reducing illness in homes, and short-term tolerance is not the same as safety under years of repeated exposure.

The rule also demonstrates how old over-the-counter ingredients can face new scrutiny as detection methods and scientific standards change. The marketplace grew before manufacturers were required to answer questions now considered basic for products used every day across a population.

Consumers will not need to discard every product immediately. The one-year transition gives companies time to reformulate, and many already have. But the direction is clear. For routine household handwashing, the government’s conclusion is that the familiar combination of plain soap, water and thorough technique remains the benchmark—and that an antibacterial claim must be proven, not presumed.